We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves New Indication for J&J’s Nucynta for Diabetic Neuropathy Pain
FDA Approves New Indication for J&J’s Nucynta for Diabetic Neuropathy Pain
August 31, 2012
The FDA has approved an sNDA for Janssen Pharmaceuticals’ Nucynta ER to manage severe pain in diabetic peripheral neuropathy (DPN).